
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.730 | 2.430 | 1.700 |
Stocks | 97.570 | 97.570 | 0.000 |
Bonds | 1.700 | 1.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.524 | 19.779 |
Price to Book | 5.584 | 4.043 |
Price to Sales | 1.590 | 2.422 |
Price to Cash Flow | 16.769 | 16.160 |
Dividend Yield | 1.105 | 1.381 |
5 Years Earnings Growth | 11.371 | 12.141 |
Number of long holdings: 65
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.51 | 867.05 | +1.15% | |
UnitedHealth | US91324P1021 | 7.46 | 511.04 | +2.06% | |
Novo Nordisk B | DK0062498333 | 5.88 | 597.5 | +1.79% | |
Merck&Co | US58933Y1055 | 5.28 | 85.60 | +2.77% | |
AstraZeneca | GB0009895292 | 4.98 | 11,704.0 | -0.71% | |
Boston Scientific | US1011371077 | 3.90 | 105.67 | +0.30% | |
Intuitive Surgical | US46120E6023 | 3.55 | 608.48 | +1.26% | |
McKesson | US58155Q1031 | 2.92 | 602.74 | +0.55% | |
Amgen | US0311621009 | 2.81 | 294.27 | +0.50% | |
Stryker | US8636671013 | 2.46 | 388.52 | +0.75% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond | 47.78B | 7.68 | 5.23 | 10.04 | ||
SEB Sverige Indexfond utd | 47.78B | 7.68 | 5.23 | 10.04 | ||
SEB Sverige Indexfond Institutional | 47.78B | 8.76 | -0.92 | 10.09 | ||
SEB Varldenfond | 41.69B | 3.49 | 8.11 | 6.74 | ||
SEB Sverige Smabol C R utd | 28.33B | 6.20 | 6.08 | 17.10 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review